Repligen Maintains Buy Rating from Craig-Hallum Analyst

Craig-Hallum analyst Matt Hewitt maintained a Buy rating on Repligen (RGEN) with an average return of -4.9% and a 41.07% success rate. Repligen's shares closed at $117.13. The company has a market cap of $6.58B and a P/E ratio of -284.57. Another analyst, Steven Etoch from Stephens, also maintained a Buy rating on July 21, while TR | OpenAI – 4o reiterated a Hold rating on July 15.

Repligen (RGEN) has seen a mix of analyst sentiments in recent months, with a majority of analysts maintaining their Buy ratings while a few have reiterated Hold positions. According to TipRanks, as of July 2025, 15 analysts have provided ratings for Repligen, with 11 analysts rating it as a Moderate Buy, 4 analysts rating it as a Hold, and no analysts rating it as a Sell.

Among the analysts, Craig-Hallum's Matt Hewitt maintained a Buy rating on Repligen with an average return of -4.9% and a 41.07% success rate [1]. Steven Etoch from Stephens also reiterated a Buy rating on July 21 [2]. Meanwhile, TR | OpenAI – 4o reiterated a Hold rating on July 15 [3].

Repligen's stock closed at $117.13 on July 2, 2025, with a market capitalization of $6.58 billion and a P/E ratio of -284.57. The company's 12-month price target average is $173.33, representing a potential 47.98% upside from its current price [1].

In terms of earnings and sales forecasts, Repligen is expected to beat its earnings estimate of $0.39 for the next quarter, with a range of $0.35 to $0.44 [1]. The company's sales forecast for the next quarter is $175.18 million, with a range of $168.80 million to $180.00 million [1].

References:
[1] https://www.tipranks.com/stocks/rgen/forecast
[2] https://www.tipranks.com/stocks/rgen/forecast
[3] https://www.tipranks.com/stocks/rgen/forecast